Abstract
Neutrophil-dominated inflammation plays an important role in many airway diseases including asthma, chronic obstructive pulmonary disease (COPD), bronchiolitis and cystic fibrosis. In cases of asthma where neutrophil-dominated inflammation is a major contributing factor to the disease, treatment with corticosteroids can be problematic as corticosteroids have been shown to promote neutrophil survival which, in turn, accentuates neutrophilic inflammation. In light of such cases, novel targeted medications must be developed that could control neutrophilic inflammation while still maintaining their antibacterial/anti-fungal properties, thus allowing individuals to maintain effective innate immune responses to invading pathogens. The aim of this review is to describe the molecular mechanisms of neutrophil apoptosis and how these pathways are modulated by glucocorticoids. These new findings are of potential clinical value and provide further insight into treatment of neutrophilic inflammation in lung disease.
Keywords: Apoptosis, glucocorticoid, inflammation, neutrophils, airway diseases, infection, caspases, Bcl-2, Dex, asthma, signaling pathway
Current Drug Targets
Title: The Molecular Mechanisms of Glucocorticoids-Mediated Neutrophil Survival
Volume: 12 Issue: 4
Author(s): Arash S. Saffar, Heather Ashdown and Abdelilah S. Gounni
Affiliation:
Keywords: Apoptosis, glucocorticoid, inflammation, neutrophils, airway diseases, infection, caspases, Bcl-2, Dex, asthma, signaling pathway
Abstract: Neutrophil-dominated inflammation plays an important role in many airway diseases including asthma, chronic obstructive pulmonary disease (COPD), bronchiolitis and cystic fibrosis. In cases of asthma where neutrophil-dominated inflammation is a major contributing factor to the disease, treatment with corticosteroids can be problematic as corticosteroids have been shown to promote neutrophil survival which, in turn, accentuates neutrophilic inflammation. In light of such cases, novel targeted medications must be developed that could control neutrophilic inflammation while still maintaining their antibacterial/anti-fungal properties, thus allowing individuals to maintain effective innate immune responses to invading pathogens. The aim of this review is to describe the molecular mechanisms of neutrophil apoptosis and how these pathways are modulated by glucocorticoids. These new findings are of potential clinical value and provide further insight into treatment of neutrophilic inflammation in lung disease.
Export Options
About this article
Cite this article as:
S. Saffar Arash, Ashdown Heather and S. Gounni Abdelilah, The Molecular Mechanisms of Glucocorticoids-Mediated Neutrophil Survival, Current Drug Targets 2011; 12(4) . https://dx.doi.org/10.2174/138945011794751555
DOI https://dx.doi.org/10.2174/138945011794751555 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Adverse Drug Reactions and Safety Considerations of NSAIDs: Clinical Analysis
Current Drug Safety QSAR and Docking Studies on Propenone Derivatives as Dual COX and 5- LOX Inhibitors
Letters in Organic Chemistry Hypersensitivity to Hymenoptera Venom: Advances in Diagnosis and Implications for Treatment
Recent Patents on Inflammation & Allergy Drug Discovery MRI of Central Nervous System (CNS) Vasculitis
Current Medical Imaging Local Inflammation in Chronic Upper Airway Disease
Current Pharmaceutical Design An Updated Meta-Analysis of the Efficacy and Safety of Acupuncture Treatment for Vascular Cognitive Impairment Without Dementia
Current Neurovascular Research Simultaneous Analysis of Ipratropium Bromide and its Related Substances Using HPLC
Current Pharmaceutical Analysis Editorial (Thematic Issue: Chemoinformatics Models for Pharmaceutical Design, Part 2)
Current Pharmaceutical Design Long Chain n-3 Polyunsaturated Fatty Acids in the Prevention of Allergic and Cardiovascular Disease
Current Pharmaceutical Design Inhibitory effects of the Food Azo Dyes on Pig Liver Carboxylesterase Activity
Current Enzyme Inhibition Mechanisms of Corticosteroid Resistance in Severe Asthma and Chronic Obstructive Pulmonary Disease (COPD)
Current Pharmaceutical Design Arylsulphones: A Promising Class of Non-Nucleoside Antiviral Agents
Current Medicinal Chemistry - Anti-Infective Agents Neutrophil-Derived Cytokines: Potential Therapeutic Targets in Inflammation
Current Drug Targets - Inflammation & Allergy Expression, Distribution and Regulation of Phosphodiesterase 5
Current Pharmaceutical Design The Optimal Treatment of Severe Hypertension in Pregnancy: Update of the Role of Nicardipine
Current Pharmaceutical Biotechnology Nasal Polyposis: An Overview of Differential Diagnosis and Treatment
Recent Patents on Inflammation & Allergy Drug Discovery Editorial [Hot Topic: Pediatricians Role in Tobacco Prevention and Control (Guest Editors: Norman Hymowitz, Dana Best and Joseph V. Schwab)]
Current Pediatric Reviews Current Status of Anti-Picornavirus Therapies
Current Pharmaceutical Design Oxidative Stress and Antioxidant Potential of One Hundred Medicinal Plants
Current Topics in Medicinal Chemistry Emerging Nanonisation Technologies: Tailoring Crystalline Versus Amorphous Nanomaterials
Current Topics in Medicinal Chemistry